✦ LIBER ✦

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer

✍ Scribed by Francesco Cognetti; Paolo Carlini; Enzo Maria Ruggeri; Fabrizio Ambesi Impiombato; Maria Rosaria Del Vecchio; Paola Pinnaro; Diana Giannarelli; Annibale Perrino

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 919 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880715)62:2<251::aid-cncr2820620205>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation between response to cisplati

Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

✍ John F. Ensley; John R. Jacobs; Arthur Weaver; Jeannie Kinzie; John Crissman; Ju 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

Usefulness of MRI volumetric evaluation

Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy

✍ Mehran Baghi; Martin G. Mack; Markus Hambek; Sotirios Bisdas; Ramona Muerthel; J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

## Abstract ## Background. The purpose was to evaluate the efficacy of tumor volumetry on MRI as predictive of response to treatment with induction chemotherapy, comparing the results with endoscopy. ## Methods: Fifty patients with advanced squamous cell carcinoma of the head and neck (SSCHN) wh

Induction paclitaxel in previously untre

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck : A Phase II trial

✍ John C. Grecula; Roy E. Smith; Chris A. Rhoades; Pramod Sharma; Amit Agrawal; Ho 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 3 views

Neoadjuvant chemotherapy/gefitinib follo

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

✍ John D. Hainsworth; David R. Spigel; Howard A. Burris III; Tiffanie M. Markus; D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Survival in patients with recurrent squa

Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

✍ Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results

A phase II study of adriamycin in previo

A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck

✍ Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval